DatReal

ANNE MEDICAL OÜ — Financial statements & reports

Name: Datreal.com Company Registry
Creator: Datreal.com
License: https://opendatacommons.org/licenses/by/1.0/

Income statement

Income statement
Year	Revenue	Inventory changes	Long-term investment expenses	Other operating income (by nature)	Material expenses	Labour expenses	Depreciation	Cost of goods sold	Gross profit	Selling expenses	Administrative expenses	Other operating income (by function)	Other operating expenses	Profit from equity investments	Other long-term investment income	Interest income	Investment revaluation	Interest expenses	Extraordinary income	Extraordinary expenses	Profit before taxes	Income tax provisions	Profit after taxes	Other taxes	Extraordinary dividends	Net profit
2026	0 €	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2025	0 €	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Year	Assets					Assets					Liabilities				Equity		Total liabilities & equity
Year	Cash	Securities	Receivables	Inventories	Total current assets	Investments	Intangible assets	Fixed assets	Total non-current assets	Total assets	Future housing repairs	Current liabilities	Non-current liabilities	Provisions	Capital	Total equity	Total liabilities & equity
2026	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	—
2025	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	—

Year	Operating cash flow	Investing cash flow	Financing cash flow	Net cash change
2026	Not available
2025	Not available

Year	Total taxes	Change	Employees
2026	76 339 €	42.8%	10%
2026 Q2	42 701 €	26.9%	10%
2026 Q1	33 638 €	0.5%	10%
2025	133 475 €	29.6%	10%
2025 Q4	33 487 €	17.8%	10%
2025 Q3	40 724 €	14.9%	10%
2025 Q2	35 435 €	48.7%	10%
2025 Q1	23 829 €	53.3%	10%
2024	189 530 €	77.8%	10%
2024 Q4	51 073 €	8.1%	10%
2024 Q3	47 264 €	1.4%	10%
2024 Q2	47 916 €	10.7%	10%
2024 Q1	43 277 €	6.9%	10%
2023	106 583 €	29.5%	10%
2023 Q4	40 486 €	4.5%	10%
2023 Q3	38 747 €	41.7%	10%
2023 Q2	27 350 €	—	10%
2023 Q1	0 €	100.0%	10%
2022	151 136 €	—	1
2022 Q4	37 971 €	17.9%	10%
2022 Q3	46 248 €	4.7%	10%
2022 Q2	44 178 €	94.3%	10%
2022 Q1	22 739 €	—	1

Income statement
Year	Revenue	Inventory changes	Long-term investment expenses	Other operating income (by nature)	Material expenses	Labour expenses	Depreciation	Cost of goods sold	Gross profit	Selling expenses	Administrative expenses	Other operating income (by function)	Other operating expenses	Profit from equity investments	Other long-term investment income	Interest income	Investment revaluation	Interest expenses	Extraordinary income	Extraordinary expenses	Profit before taxes	Income tax provisions	Profit after taxes	Other taxes	Extraordinary dividends	Net profit
2026	0 €	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2025	0 €	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Year	Assets					Assets					Liabilities				Equity		Total liabilities & equity
Year	Cash	Securities	Receivables	Inventories	Total current assets	Investments	Intangible assets	Fixed assets	Total non-current assets	Total assets	Future housing repairs	Current liabilities	Non-current liabilities	Provisions	Capital	Total equity	Total liabilities & equity
2026	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	—
2025	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	—

Year	Operating cash flow	Investing cash flow	Financing cash flow	Net cash change
2026	Not available
2025	Not available

Year	Total taxes	Change	Employees
2026	76 339 €	42.8%	10%
2026 Q2	42 701 €	26.9%	10%
2026 Q1	33 638 €	0.5%	10%
2025	133 475 €	29.6%	10%
2025 Q4	33 487 €	17.8%	10%
2025 Q3	40 724 €	14.9%	10%
2025 Q2	35 435 €	48.7%	10%
2025 Q1	23 829 €	53.3%	10%
2024	189 530 €	77.8%	10%
2024 Q4	51 073 €	8.1%	10%
2024 Q3	47 264 €	1.4%	10%
2024 Q2	47 916 €	10.7%	10%
2024 Q1	43 277 €	6.9%	10%
2023	106 583 €	29.5%	10%
2023 Q4	40 486 €	4.5%	10%
2023 Q3	38 747 €	41.7%	10%
2023 Q2	27 350 €	—	10%
2023 Q1	0 €	100.0%	10%
2022	151 136 €	—	1
2022 Q4	37 971 €	17.9%	10%
2022 Q3	46 248 €	4.7%	10%
2022 Q2	44 178 €	94.3%	10%
2022 Q1	22 739 €	—	1